The enemy at home: leishmaniasis in the Mediterranean basin, Italy on the focus

References

• Akhoundi M, Downing T, Votýpka J, et al. Leishmania infections: molecular targets and diagnosis. Mol Aspects Med. 2017;57:1–29.
   PubMed Web of Science ®Google Scholar
• Van der Auwera G, Dujardin JC. Species typing in dermal leishmaniasis. Clin Microbiol Rev. 2015;28:265–294.
   PubMed Web of Science ®Google Scholar
• Stark D, van Hal S, Lee R, et al. Leishmaniasis, an emerging imported infection: report of 20 cases from Australia. J Travel Med. 2008;15:351–354.
   PubMed Web of Science ®Google Scholar
• Rose K, Curtis J, Baldwin T, et al. Cutaneous leishmaniasis in red kangaroos: isolation and characterisation of the causative organisms. Int J Parasitol. 2004;34:655–664.
   PubMed Web of Science ®Google Scholar
• Stamper LW, Patrick RL, Fay MP, et al. Infection parameters in the sand fly vector that predict transmission of leishmania major. PLoS Negl Trop Dis. 2011;5:e1288.
   PubMed Web of Science ®Google Scholar
• Louradour I, Monteiro CC, Inbar E, et al. The midgut microbiota plays an essential role in sand fly vector competence for leishmania major. Cell Microbiol. 2017;19:1-20.
   Web of Science ®Google Scholar
• Courtenay O, Peters NC, Rogers ME, et al. Combining epidemiology with basic biology of sand flies, parasites, and hosts to inform leishmaniasis transmission dynamics and control. PLoS Pathog. 2017;13:e1006571.
   PubMed Web of Science ®Google Scholar
• Kelly PH, Bahr SM, Serafim TD, et al. The gut microbiome of the vector Lutzomyia longipalpis is essential for survival of leishmania infantum. MBio. 2017;8:1-12.
   Web of Science ®Google Scholar
• Bates PA, Depaquit J, Galati EA, et al. Recent advances in phlebotomine sand fly research related to leishmaniasis control. Parasit Vectors. 2015;8:131.
   PubMed Web of Science ®Google Scholar
• Killick-Kendrick R, Molyneux DH. Transmission of leishmaniasis by the bite of phlebotomine sandflies: possible mechanisms. Trans R Soc Trop Med Hyg. 1981;75:152–154.
   PubMed Web of Science ®Google Scholar
• Lodge R, Descoteaux A. Leishmania invasion and phagosome biogenesis. Subcell Biochem. 2008;47:174–181.
   PubMedGoogle Scholar
• Moradin N, Descoteaux A. Leishmania promastigotes: building a safe niche within macrophages. Front Cell Infect Microbiol. 2012;2:121.
   PubMed Web of Science ®Google Scholar
• Real F, Florentino PT, Reis LC, et al. Cell-to-cell transfer of Leishmania amazonensis amastigotes is mediated by immunomodulatory LAMP-rich parasitophorous extrusions. Cell Microbiol. 2014;16:1549–1564.
   PubMed Web of Science ®Google Scholar
• Petropolis DB, Rodrigues JCF, Viana NB, et al. Leishmania amazonensis promastigotes in 3D collagen I culture: an in vitro physiological environment for the study of extracellular matrix and host cell interactions. PEERJ. 2014;2:e317.
   PubMed Web of Science ®Google Scholar
• Beattie L, Kaye PM. Leishmania-host interactions: what has imaging taught us? Cell Microbiol. 2011;13:1659–1667.
   PubMed Web of Science ®Google Scholar
• Basso MA, Marques C, Santos M, et al. Successful treatment of feline leishmaniosis using a combination of allopurinol and N-methyl-glucamine antimoniate. JFMS Open Rep. 2016;2:2055116916630002.
   Google Scholar
• Hubalek Z. Emerging human infectious diseases: anthroponoses, zoonoses, and sapronoses. Emerg Infect Dis. 2003;9:403–404.
   PubMed Web of Science ®Google Scholar
• Lainson R, Shaw JJ, Silveira FT, et al. The dermal leishmaniases of Brazil, with special reference to the eco-epidemiology of the disease in Amazonia. Mem Inst Oswaldo Cruz. 1994;89:435–443.
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). Control of the leishmaniases. Geneva: WHO; 2010.
   Google Scholar
• Millàn J, Ferroglio E, Solano-Gallego L. Role of wildlife in the epidemiology of Leishmania infantum infection in Europe. Parasitol Res. 2014;113:2005–2014. DOI:10.1007/s00436-014-3929-2
   PubMedGoogle Scholar
• Michel G, Pomares C, Ferrua B, et al. Importance of worldwide asymptomatic carriers of Leishmania infantum (L. chagasi) in human. Acta Trop. 2011;119:69–75.
   PubMed Web of Science ®Google Scholar
• Quinnell RJ, Courtenay O. Transmission, reservoir hosts and control of zoonotic visceral leishmaniasis. Parasitology. 2009;136:1915–1934.
   PubMed Web of Science ®Google Scholar
• Borja LS, Sousa OMF, Solcà MDS, et al. Parasite load in the blood and skin of dogs naturally infected by Leishmania infantum is correlated with their capacity to infect sand fly vectors. Vet Parasitol. 2016;229:110–117.
   PubMed Web of Science ®Google Scholar
• Belo VS, Werneck GL, Barbosa DS, et al. Factors associated with visceral leishmaniasis in the Americas: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2013;7:e2182.
   PubMed Web of Science ®Google Scholar
• Pennisi MG, Hartmann K, Lloret A, et al. Leishmaniasis in cats: ABCD guidelines on prevention and management. J Feline Med Surg. 2013;15:638–642.
   PubMedGoogle Scholar
• Gramiccia M, Gradoni L. The current status of zoonotic leishmaniases and approaches to disease control. Int J Parasitol. 2005;35:1169–1180.
   PubMed Web of Science ®Google Scholar
• Carrillo E, Moreno J, Cruz I. What is responsible for a large and unusual outbreak of leishmaniasis in Madrid? Trends Parasitol. 2013;29:579–580.
   PubMed Web of Science ®Google Scholar
• Garcia N, Moreno I, Alvarez J, et al. Evidence of Leishmania infantum infection in rabbits (Oryctolagus cuniculus) in a natural area in Madrid, Spain. Biomed Res Int. 2014;318254.
   PubMed Web of Science ®Google Scholar
• Karayiannis S, Ntais P, Messaritakis I, et al. Detection of Leishmania Infantum in red foxes (Vulpes vulpes) in Central Greece. Parasitology. 2015;142:1574–1578.
   PubMed Web of Science ®Google Scholar
• Paniz Mondolfi AE, Colmenares Garmendia A, Mendoza Pérez Y, et al. Autochthonous cutaneous leishmaniasis in urban domestic animals (Felis catus/Canis lupus familiaris) from central-western Venezuela. Acta Trop. 2019;191:252–260.
   PubMed Web of Science ®Google Scholar
• Cupolillo E, Momen H, Grimaldi G Jr. Genetic diversity in natural populations of new world leishmania. Mem Inst Oswaldo Cruz. 1998;93:663–668.
   PubMed Web of Science ®Google Scholar
• Cupolillo AL, Kindt A, Quispe-Tintaya KW, et al. American tegumentary leishmaniasis: antigen-gene polymorphism, taxonomy and clinical pleomorphism. Infect Genet Evol. 2005;5:109–116.
   PubMedGoogle Scholar
• Quaresma PF, de Brito CFA, Rugani JMN, et al. Distinct genetic profiles of leishmania (Viannia) braziliensis associate with clinical variations in cutaneous-leishmaniasis patients from an endemic area in Brazil. Parasitology. 2018;145:1161–1169.
   PubMed Web of Science ®Google Scholar
• [cited 2020 Jan 7]. Available from: www.who.int/news-room/fact-sheets/detail/leishmaniasis.
   Google Scholar
• Oryan A, Akbari M. Worldwide risk factors in leishmaniasis. Asian Pac J Trop Med. 2016;9:925–932.
   PubMed Web of Science ®Google Scholar
• Yared S, Deribe K, Gebreselassie A, et al. Risk factors of visceral leishmaniasis: a case control study in north-western Ethiopia. Parasit Vectors. 2014;7:470.
   PubMed Web of Science ®Google Scholar
• Ruh E, Bostanci A, Kunter V, et al. Leishmaniasis in Northern Cyprus: human cases and their association with risk factors. J Vector Borne Dis. 2017;54:358–365.
   PubMed Web of Science ®Google Scholar
• Norman FF, Comeche B, Chamorro S, et al. Overcoming challenges in the diagnosis and treatment of parasitic infectious diseases in migrants. Expert Rev Anti Infect Ther. 2020;18:127–143.
   Web of Science ®Google Scholar
• Rehman K, Walochnik J, Mischlinger J, et al. Leishmaniasis in Northern Syria during Civil War. Emerg Infect Dis. 2018;24:1973–1981.
   PubMed Web of Science ®Google Scholar
• Akuffo H, Costa C, van Griensven J, et al. New insights into leishmaniasis in the immunosuppressed. PLoS Negl Trop Dis. 2018;12:e0006375.
   PubMed Web of Science ®Google Scholar
• Trájer AJ. The potential impact of climate change on the seasonality of Phlebotomus neglectus, the vector of visceral leishmaniasis in the East Mediterranean region. Int J Environ Health Res. 2019;20:1–19.
   Google Scholar
• Mattin MJ, Solano-Gallego L, Dhollander S, et al. The frequency and distribution of canine leishmaniasis diagnosed by veterinary practitioners in Europe. Vet J. 2014;200:410–419.
   PubMed Web of Science ®Google Scholar
• Athanasiou LV, Kontos VI, Saridomichelakis MN, et al. A cross-sectional sero-epidemiological study of canine leishmaniasis in Greek mainland. Acta Trop. 2012;122:291–295.
   PubMed Web of Science ®Google Scholar
• Franco AO, Davies CR, Mylne A, et al. Predicting the distribution of canine leishmaniasis in western Europe based on environmental variables. Parasitology. 2011;138:1878–1891.
   PubMed Web of Science ®Google Scholar
• Martín-Sánchez J, Morales-Yuste M, Acedo-Sánchez C, et al. Canine leishmaniasis in southeastern Spain. Emerg Infect Dis. 2009;15:795–798.
   PubMed Web of Science ®Google Scholar
• Solano-Gallego L, Morell P, Arboix M, et al. Prevalence of Leishmania infantum infection in dogs living in an area of canine leishmaniasis endemicity using PCR on several tissues and serology. J Clin Microbiol. 2001;39:560–563.
   PubMed Web of Science ®Google Scholar
• Gramiccia M. Recent advances in Leishmaniasis in pet animals: epidemiology, diagnostics and anti-vectorial prophylaxis. Vet Parasitol. 2011;181:23–30.
   PubMed Web of Science ®Google Scholar
• Foglia Manzillo V, Gizzarelli M, Vitale F, et al. Serological and entomological survey of canine leishmaniasis in Lampedusa island, Italy. BMC Vet Res. 2018;14:286.
   PubMed Web of Science ®Google Scholar
• Le Rutte EA, van Straten R, Overgaauw PAM. Awareness and control of canine leishmaniasis: a survey among Spanish and French veterinarians. Vet Parasitol. 2018;253:87–93.
   PubMed Web of Science ®Google Scholar
• Velez R, Ballart C, Domenech E, et al. Seroprevalence of canine Leishmania infantum infection in the Mediterranean region and identification of risk factors: the example of North-Eastern and Pyrenean areas of Spain. Prev Vet Med. 2019;162:67–75.
   PubMed Web of Science ®Google Scholar
• Anstead GM, Chandrasekar B, Zhao W, et al. Malnutrition alters the innate immune response and increases early visceralization following Leishmania donovani infection. Infect Immun. 2001;69:4709–4718.
   PubMed Web of Science ®Google Scholar
• Mazzitelli M, Torti C, Greco G, et al. Prevalence of parasitic infections in migrants: do official symptom-driven guidelines apply to the current situation? Infez Med. 2018;26:347–355.
   PubMedGoogle Scholar
• Özkeklikçi A, Karakuş M, Özbel Y, et al. The new situation of cutaneous leishmaniasis after Syrian civil war in Gaziantep city, Southeastern region of Turkey. Acta Trop. 2017;166:35–38.
   PubMed Web of Science ®Google Scholar
• Nimer NA. A review on emerging and reemerging of infectious diseases in Jordan: the aftermath of the Syrian crises. Can J Infect Dis Med Microbiol. 2018;2018:8679174.
   PubMed Web of Science ®Google Scholar
• El Safadi D, Merhabi S, Rafei R, et al. Cutaneous leishmaniasis in north Lebanon: re-emergence of an important neglected tropical disease. Trans R Soc Trop Med Hyg. 2019;113:471–476.
   PubMed Web of Science ®Google Scholar
• Sousa-Gomes ML, Maia-Elkhoury ANS, Pelissari DM, et al. Coinfecção leishmania-HIV no Brasil: aspectos epidemiológicos, clínicos e laboratoriais. Epidemiol Serv Saúde. 2011;20:519–526.
   Google Scholar
• [cited 2020 Jan 7]. Available from: www.who.int/leishmaniasis/burden/hiv_coinfection/burden_hiv_coinfection/en/.
   Google Scholar
• Okwor I, Uzonna JE. The immunology of leishmania/HIV co-infection. Immunol Res. 2013;56:163–171.
   PubMed Web of Science ®Google Scholar
• Alemayehu M, Wubshet M, Mesfin N, et al. Prevalence of Human Immunodeficiency Virus and associated factors among visceral leishmaniasis infected patients in Northwest Ethiopia: a facility based cross-sectional study. BMC Infect Dis. 2017;17:152.
   PubMed Web of Science ®Google Scholar
• Ritmeijer K, Veeken H, Melaku Y, et al. Ethiopian visceral leishmaniasis: generic and proprietary sodium stibogluconate are equivalent; HIV co-infected patients have a poor outcome. Trans R Soc Trop Med Hyg. 2001;95:668–672.
   PubMed Web of Science ®Google Scholar
• Mulat Y, Bayeh A, Wondemagegn M, et al. Proportional of visceral leishmaniasis and human immune deficiency virus co-infection among clinically confirmed visceral leishmaniasis patients at the endemic foci of the Amahara National Regional State, North-West Ethiopia. Am J Biol Life Sci. 2014;2:1–7.
   Google Scholar
• Mengistu G, Ayele B. Visceral leishmaniasis and HIV co-infection in patients admitted to Gondar University Hospital, North West Ethiopia. Ethiop J Health Dev. 2007;21:53–60.
   Google Scholar
• Coutinho JVSC, Santos FSD, Ribeiro RDSP, et al. Visceral leishmaniasis and leishmaniasis-HIV coinfection: comparative study. Rev Soc Bras Med Trop. 2017;50:670–674.
   PubMed Web of Science ®Google Scholar
• Lindoso JAL, Moreira CHV, Cunha MA, et al. Visceral leishmaniasis and HIV coinfection: current perspectives. HIV AIDS (Auckl). 2018;10:193–201.
   PubMedGoogle Scholar
• Ritmeijer K, Dejenie A, Assefa Y, et al. A comparison of miltefosine and sodium stibogluconate for treatment of visceral leishmaniasis in an Ethiopian population with high prevalence of HIV infection. Clin Infect Dis. 2006;43:357–364.
   PubMed Web of Science ®Google Scholar
• Molina I, Falco V, Crespo M, et al. Efficacy of liposomal amphotericin B for secondary prophylaxis of visceral leishmaniasis in HIV-infected patients. J Antimicrob Chemother. 2007;60:837–842.
   PubMed Web of Science ®Google Scholar
• Gradoni L, Gramiccia M. Leishmania infantum tropism: strain genotype or host immune status? Parasitol Today. 1994;10:264–267.
   PubMedGoogle Scholar
• Sutherst RW. Global change and human vulnerability to vector-borne diseases. Clin Microbiol Rev. 2004;17:136–173. .
   PubMed Web of Science ®Google Scholar
• Neghina R, Neghina AM. Leishmaniasis, a global concern for travel medicine. Scand J Infect Dis. 2010;42:563–570.
   PubMed Web of Science ®Google Scholar
• Mansueto P, Seidita A, Vitale G, et al. Leishmaniasis in travelers: a literature review. Travel Med Infect Dis. 2014;12:563–581.
   PubMed Web of Science ®Google Scholar
• Ergen EN, King AH, Tuli M. Cutaneous leishmaniasis: an emerging infectious disease in travelers. Cutis. 2015;96:E22–E26.
   PubMed Web of Science ®Google Scholar
• Pavel G, Timofte D, Mocanu D, et al. Imported leishmaniasis in a dog in a sandfly-populated area in northeastern Romania. J Vet Diagn Invest. 2017;29:683–685.
   PubMed Web of Science ®Google Scholar
• Obwaller AG, Köhsler M, Poeppl W, et al. Leishmania infections in Austrian soldiers returning from military missions abroad: a cross-sectional study. Clin Microbiol Infect. 2018;24:1100.e1–1100.
   PubMed Web of Science ®Google Scholar
• Perez-Ayala A, Norman F, Perez-Molina JA, et al. Imported leishmaniasis: a heterogeneous group of diseases. J Travel Med. 2009;16:395–401.
   PubMed Web of Science ®Google Scholar
• Stamm LV. Human migration and leishmaniasis-on the move. JAMA Dermatol. 2016;152:373–374.
   PubMed Web of Science ®Google Scholar
• Ju O, Grove DI, Jaksic WJ, et al. Visceral leishmaniasis: a trip to the Greek Islands is not always idyllic. Med J Aust. 2004;181:446–447.
   PubMed Web of Science ®Google Scholar
• Bart A, van Thiel PP, de Vries HJ, et al. Imported leishmaniasis in the Netherlands from 2005 to 2012: epidemiology, diagnostic techniques and sequence-based species typing from 195 patients. Euro Surveill. 2013;18:20544.
   PubMedGoogle Scholar
• Di Muccio T, Scalone A, Bruno A, et al. Epidemiology of imported leishmaniasis in Italy: implications for a European endemic country. PLoS One. 2015;10:e0129418.
   PubMed Web of Science ®Google Scholar
• Trück J, Rampton C, Kelly SJ, et al. Visceral leishmaniasis in an infant following a holiday trip to Spain. BMJ Case Rep. 2015;2015:1-3.
   Google Scholar
• Wollina U, Koch A, Schönlebe J, et al. Non-healing facial lesions: cutaneous old world leishmaniasis in Dresden. J Biol Regul Homeost Agents. 2015;29:99–102.
   PubMedGoogle Scholar
• Patel TA, Scadding GK, Phillips DE, et al. Case report: old world mucosal leishmaniasis: report of five imported cases to the hospital for tropical diseases, London, United Kingdom. Am J Trop Med Hyg. 2017;97:1116–1119.
   PubMed Web of Science ®Google Scholar
• Adamczick C, Dierig A, Welzel T, et al. Double trouble: visceral leishmaniasis in twins after traveling to Tuscany - a case report. BMC Infect Dis. 2018;18:495.
   PubMed Web of Science ®Google Scholar
• Asbury K, Seville MT, Pritt B, et al. The brief case: the unexpected Souvenir. J Clin Microbiol. 2018;56:1-7.
   Web of Science ®Google Scholar
• [cited 2020 Jan 7]. Available from: www.who.int/gho/neglected_diseases/leishmaniasis/en/
   Google Scholar
• Blagrove MSC, Caminade C, Waldmann E, et al. Co-occurrence of viruses and mosquitoes at the vectors’ optimal climate range: an underestimated risk to temperate regions? PLoS Negl Trop Dis. 2017;11:e0005604.
   PubMed Web of Science ®Google Scholar
• Semenza JC, Suk JE. Vector-borne diseases and climate change: a European perspective. FEMS Microbiol Lett. 2018;365:1-9.
   Web of Science ®Google Scholar
• Kasap OE, Alten B. Comparative demography of the sand fly Phlebotomus papatasi (Diptera: Psychodidae) at constant temperatures. J Vector Ecol. 2006;31:378–385.
   PubMed Web of Science ®Google Scholar
• Simsek FM, Alten B, Caglar SS, et al. Distribution and altitudinal structuring of phlebotomine sand flies (Diptera: Psychodidae) in southern Anatolia, Turkey: their relation to human cutaneous leishmaniasis. J Vector Ecol. 2007;32:285–291.
   PubMed Web of Science ®Google Scholar
• Kasap OE, Alten B. Laboratory estimation of degree-day developmental requirements of Phlebotomus papatasi (Diptera: Psychodidae). J Vector Ecol. 2005;30:328–333.
   PubMed Web of Science ®Google Scholar
• Wollina U, Koch A, Guarneri C, et al. Cutaneous leishmaniasis - A case series from Dresden. Open Access Maced J Med Sci. 2018;6:89–92.
   PubMedGoogle Scholar
• Koch LK, Kochmann J, Klimpel S, et al. Modeling the climatic suitability of leishmaniasis vector species in Europe. Sci Rep. 2017;7:13325.
   PubMed Web of Science ®Google Scholar
• Rossati A, Bargiacchi O, Kroumova V, et al. Vector transmitted diseases and climate changes in Europe. Infez Med. 2014;22:179–192.
   PubMedGoogle Scholar
• Baxarias M, Álvarez-Fernández A, Martínez-Orellana P, et al. Does co-infection with vector-borne pathogens play a role in clinical canine leishmaniosis? Parasit Vectors. 2018;11:135.
   PubMed Web of Science ®Google Scholar
• Antoniou M, Gramiccia M, Molina R, et al. The role of indigenous phlebotomine sandflies and mammals in the spreading of leishmaniasis agents in the Mediterranean region. Euro Surveill. 2013;18:54–61.
   Google Scholar
• Fischer D, Thomas SM, Beierkuhnlein C. Modelling climatic suitability and dispersal for disease vectors: the example of a phlebotomine sandfly in Europe. Procedia Environ Sci. 2011;7:164–169.
   Google Scholar
• Pearson RD, Sousa ADQ. Clinical spectrum of leishmaniasis. Clin Infect Dis. 1996;22:1–13.
   PubMed Web of Science ®Google Scholar
• [cited 2020 Jan 7]. Available from: www.cdc.gov/parasites/leishmaniasis/health_professionals/index.html
   Google Scholar
• Schönian G, Mauricio I, Gramiccia M, et al. Leishmaniases in the Mediterranean in the era of molecular epidemiology. Trends Parasitol. 2008;24:135–142.
   PubMed Web of Science ®Google Scholar
• Berzunza-Cruz M, Bricaire G, Salaiza Suazo N, et al. PCR for identification of species causing American cutaneous leishmaniasis. Parasitol Res. 2009;104:691–699.
   PubMed Web of Science ®Google Scholar
• Zea DF, Prager M, Figueroa RA, et al. Mucosal complication of cutaneous leishmaniasis. Biomedica. 2009;29:9–11.
   PubMed Web of Science ®Google Scholar
• Scorza BM, Wacker MA, Messingham K, et al. Differential activation of human keratinocytes by leishmania species causing localized or disseminated disease. J Invest Dermatol. 2017;137:2149–2156.
   PubMed Web of Science ®Google Scholar
• Herwaldt BL, Stokes SL, Juranek DD. American cutaneous leishmaniasis in U.S. travelers. Ann Intern Med. 1993;118:779–784.
   PubMed Web of Science ®Google Scholar
• Salman SM, Rubeiz NG, Kibbi AG. Cutaneous leishmaniasis: clinical features and diagnosis. Clin Dermatol. 1999;17:291–296.
   PubMed Web of Science ®Google Scholar
• Kroidl A, Kroidl I, Bretzel G, et al. Non-healing old world cutaneous leishmaniasis caused by L. infantum in a patient from Spain. BMC Infect Dis. 2014;14:206.
   PubMed Web of Science ®Google Scholar
• David CV 1, Craft N. Cutaneous and mucocutaneous leishmaniasis. Dermatol Ther. 2009;22:491–502.
   PubMed Web of Science ®Google Scholar
• Maltezou HC. Leishmaniasis. In: Maltezou HC, Gikas A, editors. Tropical and emerging infectious diseases. Kerala (India): Research Signpost; 2010; p. 163e85.
   Google Scholar
• Marcoval J, Penín RM. Evolution of cutaneous leishmaniasis in the last 30 years in a tertiary hospital of the European Mediterranean coast. Int J Dermatol. 2017;56:750–753.
   PubMed Web of Science ®Google Scholar
• Garrido-Jareño M, Sahuquillo-Torralba A, Chouman-Arcas R, et al. Cutaneous and mucocutaneous leishmaniasis: experience of a Mediterranean hospital. Parasit Vectors. 2020;13:24.
   PubMed Web of Science ®Google Scholar
• Giavedoni P, Iranzo P, Fuertes I, et al. Cutaneous leishmaniasis: 20 years’ experience in a Spanish tertiary care hospital. Actas Dermosifiliogr. 2015;106:310–316.
   PubMed Web of Science ®Google Scholar
• Zanger P, Gabrysch S. Leishmaniasis in the era of tumor necrosis factor alpha antagonist therapy–a research agenda for Europe. Euro Surveill. 2013;18:20542.
   PubMedGoogle Scholar
• Rakotonarivo L, Lons-Danic D, Janier M. Plurifocal cutaneous leishmaniasis during treatment with ustekinumab. JAAD Case Rep. 2018;4:298–300.
   PubMedGoogle Scholar
• Amato VS 1, Tuon FF, Bacha HA, et al. Mucosal leishmaniasis. Current scenario and prospects for treatment. Acta Trop. 2008;105:1–9.
   PubMed Web of Science ®Google Scholar
• Jara M, Valencia BM, Adaui V, et al. Quantitative kinetoplast DNA assessment during treatment of mucosal leishmaniasis as a potential biomarker of outcome: a pilot study. Am J Trop Med Hyg. 2016;94:107–113.
   PubMed Web of Science ®Google Scholar
• Strazzulla A, Cocuzza S, Pinzone MR, et al. Mucosal leishmaniasis: an underestimated presentation of a neglected disease. Biomed Res Int. 2013;2013:805108.
   PubMed Web of Science ®Google Scholar
• Leitner V, Weingast J, Harmankaya K, et al. Leishmaniasis in the tongue of an immunocompetent man. Am J Trop Med Hyg. 2010;82:597–599.
   PubMed Web of Science ®Google Scholar
• Kevric I, Cappel MA, Keeling JH. New world and old world leishmania infections: a practical review. Dermatol Clin. 2015;33:579–593.
   PubMed Web of Science ®Google Scholar
• Machado-Coelho GL, Caiaffa WT, Genaro O, et al. Risk factors for mucosal manifestation of American cutaneous leishmaniasis. Trans R Soc Trop Med Hyg. 2005;99:55–61.
   PubMed Web of Science ®Google Scholar
• Ventin F, Cincurá C, Machado PRL. Safety and efficacy of miltefosine monotherapy and pentoxifylline associated with pentavalent antimony in treating mucosal leishmaniasis. Expert Rev Anti Infect Ther. 2018;16:219–225.
   PubMed Web of Science ®Google Scholar
• Berbert TRN, de Mello TFP, Wolf Nassif P, et al. Pentavalent antimonials combined with other therapeutic alternatives for the treatment of cutaneous and mucocutaneous leishmaniasis: a systematic review. Dermatol Res Pract. 2018;2018:9014726.
   PubMed Web of Science ®Google Scholar
• Goyonlo VM, Vahabi-Amlashi S, Taghavi F. Successful treatment by adding thalidomide to meglumine antimoniate in a case of refractory anthroponotic mucocutaneous leishmaniasis. Int J Parasitol Drugs Drug Resist. 2019;11:177–179.
   PubMed Web of Science ®Google Scholar
• Lima ID, Queiroz JW, Lacerda HG, et al. Leishmania infantum chagasi in Northeastern Brazil: asymptomatic infection at the urban perimeter. Am J Trop Med Hyg. 2012;86:99–107.
   PubMed Web of Science ®Google Scholar
• Takken CJM. Koenraadt. Ecology of parasite-vector interactions. Wageningen: Wageningen Academic Publishers; 2013.
   Google Scholar
• Thomaz Soccol V, Pasquali AKS, Pozzolo EM, et al. More than the eyes can see: the worrying scenario of canine leishmaniasis in the Brazilian side of the triple border. PLoS One. 2017;12:e0189182.
   PubMed Web of Science ®Google Scholar
• Ready PD. Epidemiology of visceral leishmaniasis. Clin Epidemiol. 2014;6:147–154.
   PubMed Web of Science ®Google Scholar
• Kafetzis DA, Maltezou HC. Visceral leishmaniasis in paediatrics. Curr Opin Infect Dis. 2002;15:289–294.
   PubMedGoogle Scholar
• Darcis G, Van der Auwera G, Giot JB, et al. Recurrence of visceral and muco-cutaneous leishmaniasis in a patient under immunosuppressive therapy. BMC Infect Dis. 2017;17:478.
   PubMed Web of Science ®Google Scholar
• Trigkidis K, Geladari E, Kokkinakis E, et al. Visceral leishmaniasis in a patient with rheumatoid arthritis undergoing treatment with methotrexate: case report and review of the literature. Eur J Rheumatol. 2017;4:139–141.
   PubMed Web of Science ®Google Scholar
• Loarce-Loarce-Martos J, Garrote-Corral S, Gioia F, et al. Visceral leishmaniasis in a patient with rheumatoid arthritis treated with methotrexate. Reumatol Clin. 2019;15:e130–e132.
   PubMed Web of Science ®Google Scholar
• Fletcher K, Issa R, Lockwood DN. Visceral leishmaniasis and immunocompromise as a risk factor for the development of visceral leishmaniasis: a changing pattern at the hospital for tropical diseases, London. PLoS One. 2015;10:e0121418.
   PubMed Web of Science ®Google Scholar
• Lindoso JA, Cunha MA, Queiroz IT, et al. Leishmaniasis–HIV coinfection: current challenges. HIV AIDS (Auckl). 2016;8:147–156.
   PubMedGoogle Scholar
• WHO. Leishmaniasis-Vector control. [cited 2020 Jan 7].Available from: www.who.int/leishmaniasis/vector-control/en/
   Google Scholar
• Herwaldt BL1. Leishmaniasis. Lancet. 1999 Oct 2;354(9185):1191–1199.
   PubMed Web of Science ®Google Scholar
• Maltezou HC, Siafas C, Mavrikou M, et al. Visceral leishmaniasis during childhood in southern Greece. Clin Infect Dis. 2000;31:1139–1143.
   PubMed Web of Science ®Google Scholar
• Argaw D, Mulugeta A, Herrero M, et al. Risk factors for visceral leishmaniasis among residents and migrants in Kafta-Humera, Ethiopia. PLoS Negl Trop Dis. 2013;7:e2543.
   PubMed Web of Science ®Google Scholar
• van Griensven J, Carrillo E, López-Vélez R, et al. Leishmaniasis in immunosuppressed individuals. Clin Microbiol Infect. 2014;20:286–299.
   PubMed Web of Science ®Google Scholar
• Zacarias DA, Rolão N, de Pinho FA, et al. Causes and consequences of higher leishmania infantum burden in patients with kala-azar: a study of 625 patients. Trop Med Int Health. 2017;22:679–687.
   PubMed Web of Science ®Google Scholar
• Besada E, Njålla RJ, Nossent JC. Imported case of visceral leishmaniasis presenting as pancytopenia in a Norwegian patient treated with methotrexate and etanercept for psoriasis arthritis. Rheumatol Int. 2013;33:2687–2689.
   PubMed Web of Science ®Google Scholar
• Reina D, Cerdà D, Güell E, et al. Visceral leishmaniasis in a rheumatoid arthritis patient receiving methotrexate. Reumatol Clin. 2017;13:354–356.
   PubMed Web of Science ®Google Scholar
• Carrasco-Antón N, López-Medrano F, Fernández-Ruiz M, et al. Environmental factors as key determinants for visceral leishmaniasis in solid organ transplant recipients, Madrid, Spain. Emerg Infect Dis. 2017;23:1155–1159.
   PubMed Web of Science ®Google Scholar
• Alvar J, Vélez ID, Bern C, et al. Leishmaniasis worldwide and global estimates of its incidence. PLoS One. 2012;7:e35671.
   PubMed Web of Science ®Google Scholar
• Aoun K, Bouratbine A. Cutaneous leishmaniasis in North Africa: a review. Parasite. 2014;21:14.
   PubMed Web of Science ®Google Scholar
• Lachaud L, Dedet JP, Marty P, et al. Surveillance of leishmaniases in France, 1999 to 2012. Euro Surveill. 2013;18:1-7.
   Google Scholar
• Castberg FC, Poulsen A, Petersen BL, et al. Visceral leishmaniasis in two children after vacation in Southern Europe. Ugeskr Laeger. 2013;175:2193–2194.
   PubMedGoogle Scholar
• Gradoni L. Epidemiological surveillance of leishmaniasis in the European Union: operational and research challenges. Euro Surveill. 2013;18:20539.
   PubMedGoogle Scholar
• Amro A, Al-Dwibe H, Gashout A, et al. Spatiotemporal and molecular epidemiology of cutaneous leishmaniasis in Libya. PLoS Negl Trop Dis. 2017;11:e0005873.
   PubMed Web of Science ®Google Scholar
• Samy AM, Annajar BB, Dokhan MR, et al. Coarse-resolution ecology of etiological agent, vector, and reservoirs of zoonotic cutaneous leishmaniasis in Libya. PLoS Negl Trop Dis. 2016;10:e0004381.
   PubMed Web of Science ®Google Scholar
• Mniouil M, Fellah H, Amarir F, et al. Epidemiological characteristics of visceral leishmaniasis in Morocco (1990–2014): an update. Acta Trop. 2017;170:169–177.
   PubMed Web of Science ®Google Scholar
• Adel A, Boughoufalah A, Saegerman C, et al. Epidemiology of visceral leishmaniasis in Algeria: an update. PLoS One. 2014;9:0099207.
   Web of Science ®Google Scholar
• Dujardin JC, Campino L, Cañavate C, et al. Spread of vector-borne diseases and neglect of leishmaniasis, Europe. Emerg Infect Dis. 2008;14:1013–1018.
   PubMed Web of Science ®Google Scholar
• Laboudi M. Epidemiological profile of cutaneous leishmaniasis in Morocco, 2004–2013. Med Sante Trop. 2017;27:44–51.
   PubMed Web of Science ®Google Scholar
• Talmoudi K, Bellali H, Ben-Alaya N, et al. Modeling zoonotic cutaneous leishmaniasis incidence in central Tunisia from 2009–2015: forecasting models using climate variables as predictors. PLoS Negl Trop Dis. 2017;11:e0005844.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Control in selected countries of the WHO Eastern Mediterranean and African regions. Casablanca Morocco; WHO. 2014 June 23–24.
   Google Scholar
• Chaffai M, Ben Rachid MS, Ben Ismail R, et al. Formes clinico-épidémiologiques des leishmanioses cutanées en Tunisie. Ann Dermatol Vénéréol. 1988;115:1255–1260.
   PubMedGoogle Scholar
• Ben Ismail R, Gradoni L, Gramiccia M, et al. Epidemic cutaneous leishmaniasis in Tunisia: biochemical characterization of parasites. Trans R Soc Trop Med Hyg. 1986;80:669–670.
   PubMed Web of Science ®Google Scholar
• Kallel K, Haouas N, Pratlong F, et al. La leishmaniose cutanée due à Leishmania infantum MON-24 en Tunisie: extension du foyer vers le centre du pays. Bull Soc Pathol Exot. 2008;101:30–31.
   Google Scholar
• Pace D, Williams TN, Grochowska A, et al. Manifestations of paediatric Leishmania infantum infections in Malta. Travel Med Infect Dis. 2011;9:37–46.
   PubMed Web of Science ®Google Scholar
• Fenech FF. Leishmaniasis in Malta and the Mediterranean basin. Ann Trop Med Parasitol. 1997;91:747–753.
   PubMed Web of Science ®Google Scholar
• Campino L, Maia C. Epidemiology of leishmaniases in Portugal. Acta Med Port. 2010;23:859–864.
   PubMed Web of Science ®Google Scholar
• Arce A, Estirado A, Ordobas M, et al. Re-emergence of leishmaniasis in Spain: community outbreak in Madrid, Spain, 2009 to 2012. Euro Surveill. 2013;18:20546.
   PubMedGoogle Scholar
• Roth-Damas P, Sempere-Manuel M, Mialaret-Lahiguera A, et al. Community outbreak of cutaneous leishmaniasis in La Ribera region of Valencia, Spain: public health measures. Enferm Infecc Microbiol Clin. 2017;35:338–343.
   PubMed Web of Science ®Google Scholar
• Tartaglia P. Visceral and cutaneous leishmaniasis in Dalmatia. Lijec Vjesn. 1957;79:511–522.
   Google Scholar
• Punda-Polić V, Sardelic S, Bradaric N. Visceral leishmaniasis in Southern Croatia. Lancet. 1998;351:188.
   PubMed Web of Science ®Google Scholar
• Zivicnjak T, Martinkovic F, Marinculic A, et al. A seroepidemiologic survey of canine visceral leishmaniasis among apparently healthy dog in Croatia. Vet Parasitol. 2005;131:35–43.
   PubMed Web of Science ®Google Scholar
• Mulic R, Custovic A, Ropac D, et al. Occurrence of visceral and cutaneous leishmaniasis in Croatia. Mil Med. 2009;174:206–211.
   PubMed Web of Science ®Google Scholar
• Šiško-Kraljević K, Jerončić A, Mohar B, et al. Asymptomatic leishmania infantum infections in humans living in endemic and non-endemic areas of Croatia, 2007 to 2009. Euro Surveill. 2013;18:20533.
   PubMedGoogle Scholar
• Tartaglia P. Kala-Azar in Dalmatia. Higijena. 1949;1:320–329.
   Google Scholar
• Bosnic S, Gradoni L, Khoury C, et al. A review of Leishmaniasis in Dalmatia (Croatia) and results from recent surveys on phlebotomine sandflies in three southern counties. Acta Trop. 2006;99:42–49.
   PubMed Web of Science ®Google Scholar
• Medenica S, Jovanović S, Dožić I, et al. Epidemiological surveillance of leishmaniasis in Montenegro, 1992–2013. Srp Arh Celok Lek. 2015;143:707–711.
   PubMed Web of Science ®Google Scholar
• Velo E, Bino S, Kuli-Lito G, et al. Recrudescence of visceral leishmaniasis in Albania: retrospective analysis of cases during 1997 to 2001 and results of an entomological survery carried out during 2001 in some districts. Trans R Soc Trop Med Hyg. 2003;97:288–290.
   PubMed Web of Science ®Google Scholar
• Petrela R, Kuneshka L, Foto E, et al. Pediatric visceral leishmaniasis in Albania: a retrospective analysis of 1,210 consecutive hospitalized patients (1995–2009). PLoS Negl Trop Dis. 2010;4:1-5.
   Web of Science ®Google Scholar
• Alvar J, Yactayo S, Bern C. Leishmaniasis and poverty. Trends Parasitol. 2006;22:552–557.
   PubMed Web of Science ®Google Scholar
• Gkolfinopoulou K, Bitsolas N, Patrinos S, et al. Epidemiology of human leishmaniasis in Greece, 1981–2011. Euro Surveill. 2013;18:20532.
   PubMedGoogle Scholar
• Sayili A, Ozkan AT, Schallig HD. Pediatric visceral leishmaniasis caused by leishmania infantum in Northern Cyprus. Am J Trop Med Hyg. 2016;95:1386–1388.
   PubMed Web of Science ®Google Scholar
• Ozaras R, Leblebicioglu H, Sunbul M, et al. The Syrian conflict and infectious diseases. Expert Rev Anti Infect Ther. 2016;14:547–555.
   PubMed Web of Science ®Google Scholar
• Maroli M, Rossi L, Baldelli R, et al. The northward spread of leishmaniasis in Italy: evidence from retrospective and ongoing studies on the canine reservoir and phlebotomine vectors. Trop Med Int Health. 2008;13:256–264.
   PubMed Web of Science ®Google Scholar
• Gramiccia M, Scalone A, Di Muccio T, et al. The burden of visceral leishmaniasis in Italy from 1982 to 2012: a retrospective analysis of the multi-annual epidemic that occurred from 1989 to 2009. Euro Surveill. 2013;18:20535.
   PubMedGoogle Scholar
• Varani S, Cagarelli R, Melchionda F, et al. Ongoing outbreak of visceral leishmaniasis in Bologna Province, Italy, November 2012 to May 2013. Euro Surveill. 2013;18:20530.
   PubMedGoogle Scholar
• [cited 2020 Jan 8]. Available from: http://www.who.int/leishmaniasis/resources/ITALY.pdf
   Google Scholar
• Leishmaniasis in Emilia-Romagna Region; surveillance system results: Public Health Authority Emilia Romagna; 2015. [cited 2020 Jan 7]. Available from: http://salute.regione.emilia-romagna.it/normativa-e-documentazione/rapporti/archivio/201cleishmaniasis-in-emilia-romagna-region-surveillance-system-results201d.
   Google Scholar
• Gaspari V, Ortalli M, Foschini MP, et al. New evidence of cutaneous leishmaniasis in north-eastern Italy. J Eur Acad Dermatol Venereol. 2017;31:1534–1540.
   PubMed Web of Science ®Google Scholar
• Franceschini E, Puzzolante C, Menozzi M, et al. Clinical and microbiological characteristics of visceral leishmaniasis outbreak in a Northern Italian nonendemic area: a retrospective observational study. Biomed Res Int. 2016;2016:6481028.
   PubMed Web of Science ®Google Scholar
• Varani S, Ortalli M, Attard L, et al. Serological and molecular tools to diagnose visceral leishmaniasis: 2-years’ experience of a single center in Northern Italy. PLoS One. 2017;12:e0183699.
   PubMed Web of Science ®Google Scholar
• Cesinaro AM, Nosseir S, Mataca E, et al. An outbreak of cutaneous leishmaniasis in Modena province (Northern Italy): report of 35 cases. Pathologica. 2017;109:363–367.
   PubMed Web of Science ®Google Scholar
• Bettini S, Maroli M, Gradoni L. Leishmaniasis in Tuscany (Italy): (IV) An analysis of all recorded human cases. Trans R Soc Trop Med Hyg. 1981;75:338–344.
   PubMed Web of Science ®Google Scholar
• Bettini S, Gramiccia M, Gradoni L, et al. Leishmaniasis in Tuscany (Italy): VIII. Human population response to leishmanin in the focus of Monte Argentario (Grosseto) and epidemiological evaluation. Ann Parasitol Hum Comp. 1983;58:539–547.
   PubMedGoogle Scholar
• Tordini G, Giaccherini R, Sammarro G, et al. Human leishmaniasis in Tuscany: a changing pattern of visceral disease? Ann Trop Med Parasitol. 2010;104:171–174.
   PubMed Web of Science ®Google Scholar
• Zammarchi L, Vellere I, Stella L, et al. Spectrum and burden of neglected tropical diseases observed in an infectious and tropical diseases unit in Florence, Italy (2000–2015). Intern Emerg Med. 2017;12:467–477.
   PubMed Web of Science ®Google Scholar
• Gradoni L, Pizzuti R, Scalone A, et al. Recrudescence of visceral leishmaniasis unrelated to HIV infection in the Campania region of Italy. Trans R Soc Trop Med Hyg. 1996;90:234–235.
   PubMed Web of Science ®Google Scholar
• di Martino L, Gramiccia M, Occorsio P, et al. Infantile visceral leishmaniasis in the Campania region, Italy: experience from a Paediatric Referral Centre. Parassitologia. 2004;46:221–223.
   PubMedGoogle Scholar
• [cited 2020 Jan 7]. Available from: http://www.salute.gov.it/portale/temi/datidefconsMalattie.jsp.
   Google Scholar
• Verso MG, Vitale F, Castelli G, et al. Suspected cutaneous leishmaniasis in a sample of Westerns Sicily residents: what correlation with occupation? Med Lav. 2017;108:123–129.
   PubMed Web of Science ®Google Scholar
• Horrillo L, Castro A, Matía B, et al. Clinical aspects of visceral leishmaniasis caused by L. infantum in adults. Ten years of experience of the largest outbreak in Europe: what have we learned? Parasit Vectors. 2019;12:359.
   PubMed Web of Science ®Google Scholar
• Kniha E, Walochnik J, Poeppl W, et al. Leishmania spp. seropositivity in Austrian soldiers returning from the Kosovo. Wien Klin Wochenschr. 2020;132(1–2):47–49.
   PubMed Web of Science ®Google Scholar
• ECDC. [cited 2020 Jan 8]. Available from: https://www.ecdc.europa.eu/en/leishmaniasis/facts
   Google Scholar
• Ejov M, Dagne D. Strategic framework for leishmaniasis control  in the WHO European Region 2014–2020. Available from: http://www.euro.who.int/__data/assets/pdf_file/0017/245330/Strategic-framework-for-leishmaniasis-control-in-the-WHO-European-Region-20142020.pdf?ua=1
   Google Scholar
• Volf P, Benkova I, Myskova J, et al. Increased transmission potential of leishmania major/leishmania infantum hybrids. Int J Parasitol. 2007;37:589–593.
   PubMed Web of Science ®Google Scholar
• Ravel C, Cortes S, Pratlong F, et al. First report of genetic hybrids between two very divergent leishmania species: leishmania infantum and leishmania major. Int J Parasitol. 2006;36:1383–1388.
   PubMed Web of Science ®Google Scholar
• Antoniou M, Haralambous C, Mazeris A, et al. Leishmania donovani leishmaniasis in Cyprus. Lancet Infect Dis. 2009;9:76–77.
   PubMed Web of Science ®Google Scholar
• Alvar J, Molina R, San Adrés M, et al. Canine leishmaniasis: parasitological and entomological follow-up after chemotherapy. Ann Trop Med Parasitol. 1994;88:371–378.
   PubMed Web of Science ®Google Scholar
• Dantas-Torres F, Miró G, Bowman DD, et al. Culling dogs for zoonotic visceral leishmaniasis control: the wind of change. Trends Parasitol. 2019;35:97–101.
   PubMed Web of Science ®Google Scholar
• Abbate JM, Arfuso F, Napoli E, et al. Leishmania infantum in wild animals in endemic areas of southern Italy. Comp Immunol Microbiol Infect Dis. 2019;67:101374.
   PubMed Web of Science ®Google Scholar
• Reguera RM, Morán M, Pérez-Pertejo Y, et al. Current status on prevention and treatment of canine leishmaniasis. Vet Parasitol. 2016;227:98–114.
   PubMed Web of Science ®Google Scholar
• Gianchecchi E, Fierabracci A. Gene/environment interactions in the pathogenesis of autoimmunity: new insights on the role of toll-like receptors. Autoimmun Rev. 2015;14:971–983.
   PubMed Web of Science ®Google Scholar
• Gianchecchi E, Delfino DV, Fierabracci A. NK cells in autoimmune diseases: linking innate and adaptive immune responses. Autoimmun Rev. 2018;17:142–154.
   PubMed Web of Science ®Google Scholar
• Schwartz T, Jensenius M, Blomberg B, et al. Imported visceral leishmaniasis and immunosuppression in seven Norwegian patients. Trop Dis Travel Med Vaccines. 2019;5:16.
   PubMedGoogle Scholar